Using Exercise and Electrical Brain Stimulation to Improve Memory in Dementia
EXACT
Exercise Augmenting Cognition tDCS (EXACT): A Pilot Study of a Combined Exercise and Transcranial Direct Current Stimulation Intervention for Cognition
1 other identifier
interventional
60
1 country
1
Brief Summary
Mild cognitive impairment and Alzheimer's disease are conditions that involve memory difficulties. Transcranial direct current stimulation is a type of brain stimulation. It may help improve these memory difficulties. However, it works better on active brain areas. This study looks at if combining exercise and applying current to important parts of the brain can help improve memory in people with Mild Cognitive Impairment or Alzheimer's disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2018
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 22, 2018
CompletedFirst Posted
Study publicly available on registry
September 13, 2018
CompletedStudy Start
First participant enrolled
November 28, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
August 6, 2025
CompletedMarch 30, 2026
May 1, 2025
6.7 years
August 22, 2018
March 25, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Alzheimer's Disease Assessment Scale Cog (ADAS-Cog) - Word Recognition Task errors at study endpoint (T3)
Assess recognition memory. Words incorrectly recognized will be tallied. Word Recognition scores range from 0 to 12. Higher scores represent a worse outcome.
Study endpoint (two-weeks post baseline)
Secondary Outcomes (4)
n-back reaction time at study endpoint (T3)
Study endpoint (two-weeks post baseline)
Alzheimer's Disease Assessment Scale-Cog (ADAS-Cog) - Word Recall Task at study endpoint (T3)
Study endpoint (two-weeks post baseline)
The Montreal Cognitive Assessment (MoCA) Total at study endpoint (T3)
Study endpoint (two-weeks post baseline)
The Neuropsychiatric Inventory (NPI) at study endpoint (T3)
Study endpoint (two-weeks post baseline)
Other Outcomes (1)
Concentration of blood biomarkers of brain plasticity at study endpoint (T3)
Study endpoint (two-weeks post baseline)
Study Arms (3)
Exercise and tDCS
EXPERIMENTALPatients randomized to this group will attend Toronto Rehabilitation Institute - University Health Network (TRI-UHN) for an individualized exercise program and active tDCS intervention.
Exercise Education and tDCS
OTHERPatients randomized to this group will undergo treatment as usual, receiving routine advice about physical activity and active tDCS intervention.
Exercise and Sham tDCS
OTHERPatients randomized to this group will attend TRI-UHN for an individualized exercise program and sham tDCS intervention.
Interventions
All study participants randomized to tDCS will receive active tDCS.
Participants will exercise at TRI according to an individualized exercise prescription.
Exercise education/ treatment as usual will include routine advice about physical activity for older adults.
The same procedure for tDCS will be used for the sham condition, except without active current.
Eligibility Criteria
You may qualify if:
- Males or females ≥50 years of age
- DSM-5 criteria for major or mild neurocognitive disorder due to AD or mixed AD/vascular disease
- Mild severity of impairment (standardized Mini-Mental State Examination (MMSE) score ≥19)
- Read and communicate in English
You may not qualify if:
- Change in cognitive enhancing medications (ChEIs and/or memantine) less than 3 months prior to study screen
- Change in anticonvulsants or psychotropic medications less than 1 month prior to study screen
- Currently taking benzodiazepines
- Presence of metal implants that would preclude safe use of tDCS (e.g. pace-maker)
- Significant neurological condition (e.g. epilepsy, Parkinson's disease, multiple sclerosis)
- Current psychiatric disorders (e.g. schizophrenia, bipolar disorder, depression, psychosis) or current substance use disorder
- Medical contraindications to increasing activity level according to the Canadian Society of Exercise Physiology Questionnaire
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Sunnybrook Health Sciences Centre
Toronto, Ontario, M3H0A7, Canada
Related Publications (1)
Liu CS, Herrmann N, Song BX, Ba J, Gallagher D, Oh PI, Marzolini S, Rajji TK, Charles J, Papneja P, Rapoport MJ, Andreazza AC, Vieira D, Kiss A, Lanctot KL. Exercise priming with transcranial direct current stimulation: a study protocol for a randomized, parallel-design, sham-controlled trial in mild cognitive impairment and Alzheimer's disease. BMC Geriatr. 2021 Dec 4;21(1):677. doi: 10.1186/s12877-021-02636-6.
PMID: 34863115DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- The research personnel that will be administering the cognitive assessments will be blinded to treatment allocation. The patients will be blinded to stimulation type.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 22, 2018
First Posted
September 13, 2018
Study Start
November 28, 2018
Primary Completion
August 1, 2025
Study Completion
August 6, 2025
Last Updated
March 30, 2026
Record last verified: 2025-05